{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:50:08Z","timestamp":1782100208399,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12010-026-05676-z","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:12:29Z","timestamp":1775110349000},"page":"5006-5022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and Validation of the Breast Cancer Diagnostic Biomarker SVEP1 and Its Relationship With CD8\u2009+\u2009T Cell Activation Using Bioinformatics and Machine Learning"],"prefix":"10.1007","volume":"198","author":[{"given":"Yaojun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"5676_CR1","first-page":"524","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto, A. N., Sung, H., Miller, K. D. (2022). Breast Cancer Statistics 2022 CA Cancer J Clin. ;72:524\u2013541.","journal-title":"Breast Cancer Statistics 2022 CA Cancer J Clin"},{"key":"5676_CR2","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl, S., Poortmans, P., Morrow, M., Denkert, C., & Curigliano, G. (2021). Breast cancer. Lancet, 397, 1750\u20131769.","journal-title":"Lancet"},{"key":"5676_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12905-023-02296-1","volume":"23","author":"M Safdari-Molan","year":"2023","unstructured":"Safdari-Molan, M., Mehrabi, E., Nourizadeh, R., & Eghdam-Zamiri, R. (2023). Predictors of the worry about cancer recurrence among women with breast cancer. Bmc Women\u2019S Health, 23, 131.","journal-title":"Bmc Women\u2019S Health"},{"key":"5676_CR4","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.2174\/1570180820666230818100059","volume":"21","author":"Y Fang","year":"2024","unstructured":"Fang, Y., & Xueqing, C. (2024). Zhenwu Decoction Modulates PDE3A to Alleviate Inflammation in Diabetic Nephropathy. Letters in Drug Design & Discovery, 21, 4743\u20134755.","journal-title":"Letters in Drug Design & Discovery"},{"key":"5676_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2174\/0118744710381356250429045716","volume":"18","author":"\u00d6 Atasoy","year":"2025","unstructured":"Atasoy, \u00d6., Anadol, E., Sa\u011flam, A. S. Y., et al. (2025). Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006). Current Radiopharmaceuticals, 18, 318\u2013332.","journal-title":"Current Radiopharmaceuticals"},{"key":"5676_CR6","doi-asserted-by":"publisher","first-page":"100016","DOI":"10.1016\/j.curpro.2025.100016","volume":"22","author":"Y Zou","year":"2025","unstructured":"Zou, Y., Guo, Z., Rong, R., Zhang, H., & Han, S. (2025). Exploration of atractylenolide III targeting MDM2\/p53 axis in breast cancer cell progression based on network pharmacology, molecular docking and ubiquitination analysis. Current Proteomics, 22, 100016.","journal-title":"Current Proteomics"},{"key":"5676_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold, M., Morgan, E., Rumgay, H., et al. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast, 66, 15\u201323.","journal-title":"Breast"},{"key":"5676_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2174\/0113892029357021250626210819","volume":"26 5","author":"B Wang","year":"2025","unstructured":"Wang, B., Wei, N., et al. (2025). Development of a Novel Lysosomal Gene-based Prognostic Panel and Uncovering EIF4EBP1 as a Biomarker for Breast Cancer. Current Genomics, 26 5, 368\u2013388.","journal-title":"Current Genomics"},{"key":"5676_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/exd.13256","volume":"26","author":"L Samuelov","year":"2017","unstructured":"Samuelov, L., Li, Q., Bochner, R., et al. (2017). SVEP1 plays a crucial role in epidermal differentiation. Experimental Dermatology, 26, 423\u2013430.","journal-title":"Experimental Dermatology"},{"key":"5676_CR10","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1111\/bph.15921","volume":"179","author":"GE Morris","year":"2022","unstructured":"Morris, G. E., Denniff, M. J., Karamanavi, E., et al. (2022). The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins \u03b19\u03b21 and \u03b14\u03b21. British Journal Of Pharmacology, 179, 4958\u20134973.","journal-title":"British Journal Of Pharmacology"},{"key":"5676_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2022.09.015","volume":"360","author":"IH Jung","year":"2022","unstructured":"Jung, I. H., Elenbaas, J. S., Burks, K. H., et al. (2022). Vascular smooth muscle- and myeloid cell-derived integrin \u03b19\u03b21 does not directly mediate the development of atherosclerosis in mice. Atherosclerosis, 360, 15\u201320.","journal-title":"Atherosclerosis"},{"key":"5676_CR12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/CIRCRESAHA.116.308825","volume":"120","author":"N Morooka","year":"2017","unstructured":"Morooka, N., Futaki, S., Sato-Nishiuchi, R., et al. (2017). Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling. Circ Res, 120, 1276\u20131288.","journal-title":"Circ Res"},{"key":"5676_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41467-023-36486-0","volume":"14","author":"JS Elenbaas","year":"2023","unstructured":"Elenbaas, J. S., Pudupakkam, U., Ashworth, K. J., et al. (2023). SVEP1 is an endogenous ligand for the orphan receptor PEAR1. Nature Communications, 14, 850.","journal-title":"Nature Communications"},{"key":"5676_CR14","doi-asserted-by":"publisher","first-page":"760480","DOI":"10.3389\/fcell.2021.760480","volume":"9","author":"V Tran","year":"2021","unstructured":"Tran, V., & O\u2019Neill, H. C. (2021). Role of SVEP1 in Stroma-Dependent Hematopoiesis In vitro. Front Cell Dev Biol, 9, 760480.","journal-title":"Front Cell Dev Biol"},{"key":"5676_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.gene.2012.05.015","volume":"505","author":"C Glait-Santar","year":"2012","unstructured":"Glait-Santar, C., Pasmanik-Chor, M., & Benayahu, D. (2012). Expression pattern of SVEP1 alternatively-spliced forms. Gene, 505, 137\u2013145.","journal-title":"Gene"},{"key":"5676_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.4149\/neo_2022_220614N629","volume":"69","author":"WC Gong","year":"2022","unstructured":"Gong, W. C., Han, Z. Q., Guo, M. X., et al. (2022). Decreased expression of SVEP1 is closely related to a cancer stem cell-like phenotype and poor prognosis in hepatocellular carcinoma. Neoplasma, 69, 1209\u20131216.","journal-title":"Neoplasma"},{"key":"5676_CR17","doi-asserted-by":"publisher","first-page":"1127753","DOI":"10.3389\/fgene.2022.1127753","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen, L., He, Y., Han, Z., et al. (2022). The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma. Frontiers In Genetics, 13, 1127753.","journal-title":"Frontiers In Genetics"},{"key":"5676_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cmet.2023.02.013","volume":"35","author":"CB Nava Lauson","year":"2023","unstructured":"Nava Lauson, C. B., Tiberti, S., Corsetto, P. A., et al. (2023). Linoleic acid potentiates CD8(+) T cell metabolic fitness and antitumor immunity. Cell Metab, 35, 633\u2013650e639.","journal-title":"Cell Metab"},{"key":"5676_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41423-025-01321-7","volume":"22","author":"D Zou","year":"2025","unstructured":"Zou, D., Li, X. C., & Chen, W. (2025). Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy. Cellular & Molecular Immunology, 22, 957\u2013974.","journal-title":"Cellular & Molecular Immunology"},{"key":"5676_CR20","doi-asserted-by":"publisher","first-page":"110657","DOI":"10.1016\/j.compbiomed.2025.110657","volume":"196","author":"H Li","year":"2025","unstructured":"Li, H., Huang, C., Su, R., et al. (2025). Developing a Panel of Shared Susceptibility Genes as Diagnostic Biomarkers for chronic obstructive pulmonary disease and Heart Failure. Computers In Biology And Medicine, 196, 110657.","journal-title":"Computers In Biology And Medicine"},{"key":"5676_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12967-023-04688-1","volume":"22","author":"Y Du","year":"2024","unstructured":"Du, Y., Lin, Y., Gan, L., et al. (2024). Potential crosstalk between SPP1\u2009+\u2009TAMs and CD8\u2009+\u2009exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer. J Transl Med, 22, 158.","journal-title":"J Transl Med"},{"key":"5676_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-024-03334-7","volume":"31","author":"J Lopez","year":"2025","unstructured":"Lopez, J., Powles, T., Braiteh, F., et al. (2025). Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial. Nature Medicine, 31, 152\u2013164.","journal-title":"Nature Medicine"},{"key":"5676_CR23","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F., Laversanne, M., Sung, H., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. C Ca: A Cancer Journal For Clinicians, 74, 229\u2013263.","journal-title":"C Ca: A Cancer Journal For Clinicians"},{"key":"5676_CR24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2023.08.002","volume":"29","author":"JS Elenbaas","year":"2023","unstructured":"Elenbaas, J. S., Jung, I. H., Coler-Reilly, A., et al. (2023). The emerging Janus face of SVEP1 in development and disease. Trends In Molecular Medicine, 29, 939\u2013950.","journal-title":"Trends In Molecular Medicine"},{"key":"5676_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41419-020-2535-8","volume":"11","author":"L Chen","year":"2020","unstructured":"Chen, L., Liu, D., Yi, X., et al. (2020). The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K\/Akt pathway. Cell Death And Disease, 11, 320.","journal-title":"Cell Death And Disease"},{"key":"5676_CR26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41423-024-01224-z","volume":"21","author":"Y Tang","year":"2024","unstructured":"Tang, Y., Chen, Z., Zuo, Q., & Kang, Y. (2024). Regulation of CD8\u2009+\u2009T cells by lipid metabolism in cancer progression. Cellular & Molecular Immunology, 21, 1215\u20131230.","journal-title":"Cellular & Molecular Immunology"},{"key":"5676_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s42003-025-08108-6","volume":"8","author":"X Wei","year":"2025","unstructured":"Wei, X., Xiang, X., Wang, H., et al. (2025). Tumor cell-intrinsic circular RNA circFNDC3B attenuates CD8(+) T cells infiltration in non-small cell lung cancer. Commun Biol, 8, 711.","journal-title":"Commun Biol"},{"key":"5676_CR28","doi-asserted-by":"publisher","first-page":"e001823","DOI":"10.1136\/jitc-2020-001823","volume":"9","author":"S Dai","year":"2021","unstructured":"Dai, S., Zeng, H., Liu, Z., et al. (2021). Intratumoral CXCL13(+)CD8(+)T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma. Journal For Immunotherapy Of Cancer, 9, e001823.","journal-title":"Journal For Immunotherapy Of Cancer"},{"key":"5676_CR29","doi-asserted-by":"publisher","first-page":"e33144","DOI":"10.1016\/j.heliyon.2024.e33144","volume":"10","author":"T He","year":"2024","unstructured":"He, T., Hu, C., Li, S., et al. (2024). The role of CD8(+) T-cells in colorectal cancer immunotherapy. Heliyon, 10, e33144.","journal-title":"Heliyon"},{"key":"5676_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41577-025-01221-x","volume":"26","author":"Q Sun","year":"2025","unstructured":"Sun, Q., & Dong, C. (2025). Regulators of CD8(+) T cell exhaustion. Nature Reviews Immunology, 26, 129\u2013151.","journal-title":"Nature Reviews Immunology"},{"key":"5676_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fcell.2020.00017","volume":"8","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z., Liu, S., Zhang, B., et al. (2020). T Cell Dysfunction and Exhaustion in Cancer. Front Cell Dev Biol, 8, 17.","journal-title":"Front Cell Dev Biol"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05676-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05676-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05676-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:28:43Z","timestamp":1782098923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05676-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5676"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05676-z","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"18 March 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the ethical review committee of Henan Provincial People's Hospital. Written informed consent was obtained from all enrolled patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The results presented in this paper have not been published preciously in whole or in part.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}